4//SEC Filing
Hykes Andrew 4
Accession 0001127602-25-005734
CIK 0001531048other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:01 PM ET
Size
18.5 KB
Accession
0001127602-25-005734
Insider Transaction Report
Form 4
Hykes Andrew
DirectorPresident and CEO
Transactions
- Disposition from Tender
Common Stock
2025-02-19−1,550→ 0 total(indirect: By Children) - Disposition from Tender
Common Stock
2025-02-19−1,550→ 0 total(indirect: By Children) - Disposition from Tender
Common Stock
2025-02-19−1,550→ 0 total(indirect: By Children) - Disposition from Tender
Common Stock
2025-02-19−1,000→ 0 total(indirect: By Spouse) - Award
Common Stock
2025-02-19+20,393→ 717,637 total - Disposition from Tender
Common Stock
2025-02-19−717,637→ 0 total - Disposition to Issuer
Stock Options (Right to Buy)
2025-02-19−36,085→ 0 totalExercise: $56.00→ Common Stock (36,085 underlying) - Disposition to Issuer
Stock Options (Right to Buy)
2025-02-19−44,693→ 0 totalExercise: $58.44→ Common Stock (44,693 underlying)
Footnotes (4)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2025, by and among Stryker Corporation ("Parent"), Eagle 1 Merger Sub, Inc. ("Merger Sub"), and Inari Medical, Inc. ("Issuer") on February 19, 2025 (the "Effective Time"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer ("Common Stock") was cancelled and converted into the right to receive $80.00 in cash (the "Merger Consideration"), without interest.
- [F2]Pursuant to the Merger Agreement, at the Effective Time, these performance-based restricted stock units vested based on deemed achievement of maximum performance.
- [F3]Includes 149,010 shares of restricted stock units ("RSUs"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration.
- [F4]At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement.
Documents
Issuer
Inari Medical, Inc.
CIK 0001531048
Entity typeother
Related Parties
1- filerCIK 0001806431
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:01 PM ET
- Size
- 18.5 KB